Objectives: The aim of this study was to assess the mid-term safety and efficacy of
percutaneous patent foramen ovale (PFO) closure using a bioabsorbable device (BioSTAR …

Background and Purpose—Transcatheter closure of patent foramen ovale (PFO) is
increasingly being performed and monitored with transthoracic or transesophageal …

Objective: We report our experience of transcatheter patent foramen ovale (PFO) closure
with the new Intrasept occluder. Background: The Intrasept device is the fourth generation of …

Objectives: Recurrent embolic events after device closure of patent foramen ovale (PFO)
have been related to incomplete closure. Another cause could be atrial fibrillation (AF). The …

Objectives: We sought to assess the safety and clinical efficacy of patent foramen ovale
(PFO) closure under fluoroscopic guidance only, without intraprocedural echocardiography …

Background and Purpose—We sought to evaluate the real-world rate of safety outcomes
after patent foramen ovale (PFO) closure in patients with ischemic stroke or transient …

Aims: Patients with cryptogenic embolic events and a patent foramen ovale (PFO) are at risk
of paradoxical embolism causing recurrent cerebral events; however, transcatheter PFO …

Background—Patients with ischemic stroke or transient ischemic attack presumably related
to patent foramen ovale (PFO) are at risk for recurrent cerebrovascular events. Differences in …

Percutaneous closure of patent foramen ovale (PFO) in patients with presumed paradoxical
embolism yields complete occlusion in> 90% of patients using contemporary closure …

Background In patients with cryptogenic stroke, transcatheter (TC) closure of a patent
foramen ovale (PFO) has not been shown to better prevent recurrent vascular events than …